Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
Opinion|Videos|October 14, 2024

Takeaways from the UH CINEMA Program

Key Takeaways

  • UH CINEMA addresses the complex needs of patients with overlapping cardiovascular, renal, and metabolic conditions through integrated care models.
  • Implementation challenges include coordinating multidisciplinary teams and managing resource allocation effectively.
SHOW MORE

A panel of cardiometabolic risk management experts analyzes key takeaways from the UH CINEMA Program.

Episodes in this series

Video content above is prompted by the following:

  • Let’s discuss some initiatives we have championed at our institutions. What are these initiatives and how are they impacting the care of CRM patients? Dr. Neeland: Tell us about the University Hospitals Heart & Vascular Institute’s Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (UH CINEMA).
  • How is the UH CINEMA program advancing health care for patients with overlapping heart, diabetes, and kidney issues?
  • What challenges have you experienced implementing this program?
  • What specific results can you share from this program?
  • What are future opportunities to improve CRM care based on this program?

This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.

Related Content